These innovative therapies , Retatrutide, represent a groundbreaking advancement in managing obesity and possibly related conditions . They are categorized as GLP-1 hormone stimulators, signifying they function to emulate the endogenous GLP-1 peptide, enhancing insulin production and suppressing appetite . Despite Tirzepatide each operates relative